Cargando…
Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is lim...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317935/ https://www.ncbi.nlm.nih.gov/pubmed/30622878 http://dx.doi.org/10.1002/open.201800156 |
_version_ | 1783384801356546048 |
---|---|
author | Merk, Daniel Grisoni, Francesca Schaller, Kay Friedrich, Lukas Schneider, Gisbert |
author_facet | Merk, Daniel Grisoni, Francesca Schaller, Kay Friedrich, Lukas Schneider, Gisbert |
author_sort | Merk, Daniel |
collection | PubMed |
description | The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is limited. Only four molecular frameworks account for more than 50 % of the FXR modulators annotated in ChEMBL. Here, we leverage machine learning methods to expand the chemical space of FXR‐targeting small molecules by employing an ensemble of three complementary machine learning approaches. A counter‐propagation artificial neural network, a k‐nearest neighbor learner, and a three‐dimensional pharmacophore descriptor were combined to retrieve novel FXR ligands from a collection of more than 3 million compounds. The ensemble machine learning model identified six new FXR modulators among ten top‐ranked candidates. These active hits comprise both FXR activators and antagonists with micromolar potencies. With four novel FXR ligand scaffolds, these computationally identified bioactive compounds appreciably expand the chemical space of known FXR modulators and may serve as starting points for hit‐to‐lead expansion. |
format | Online Article Text |
id | pubmed-6317935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63179352019-01-08 Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning Merk, Daniel Grisoni, Francesca Schaller, Kay Friedrich, Lukas Schneider, Gisbert ChemistryOpen Full Papers The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is limited. Only four molecular frameworks account for more than 50 % of the FXR modulators annotated in ChEMBL. Here, we leverage machine learning methods to expand the chemical space of FXR‐targeting small molecules by employing an ensemble of three complementary machine learning approaches. A counter‐propagation artificial neural network, a k‐nearest neighbor learner, and a three‐dimensional pharmacophore descriptor were combined to retrieve novel FXR ligands from a collection of more than 3 million compounds. The ensemble machine learning model identified six new FXR modulators among ten top‐ranked candidates. These active hits comprise both FXR activators and antagonists with micromolar potencies. With four novel FXR ligand scaffolds, these computationally identified bioactive compounds appreciably expand the chemical space of known FXR modulators and may serve as starting points for hit‐to‐lead expansion. John Wiley and Sons Inc. 2018-10-02 /pmc/articles/PMC6317935/ /pubmed/30622878 http://dx.doi.org/10.1002/open.201800156 Text en © 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full Papers Merk, Daniel Grisoni, Francesca Schaller, Kay Friedrich, Lukas Schneider, Gisbert Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title_full | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title_fullStr | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title_full_unstemmed | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title_short | Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning |
title_sort | discovery of novel molecular frameworks of farnesoid x receptor modulators by ensemble machine learning |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317935/ https://www.ncbi.nlm.nih.gov/pubmed/30622878 http://dx.doi.org/10.1002/open.201800156 |
work_keys_str_mv | AT merkdaniel discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning AT grisonifrancesca discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning AT schallerkay discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning AT friedrichlukas discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning AT schneidergisbert discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning |